IL13 and vitamin D deficiency: This IL-13 production solely in the vehicle-treated VDD mice might be the consequence of low levels of circulating 1α,25(OH)2D3 with vitamin D deficiency, hampering vitamin D to inhibit LPS-induced IL-13 as previously reported [32].